| 000 | 00966 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250511201043.0 | ||
| 264 | 0 | _c19900817 | |
| 008 | 199008s 0 0 eng d | ||
| 022 | _a0160-2446 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHof, R P | |
| 245 | 0 | 0 |
_aHemodynamic, antivasoconstrictor, and antiatherosclerotic effects of calcium antagonists in animal models of atherosclerosis. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _c1990 |
||
| 300 |
_aS7-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArteriosclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xtherapeutic use |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 700 | 1 | _aTapparelli, C | |
| 700 | 1 | _aWeinstein, D B | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 15 Suppl 1 _gp. S7-12 |
|
| 999 |
_c1701709 _d1701709 |
||